Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
Breast Cancer Research and Treatment, 05/08/2012
Debeb BC et al. – The data suggest that additional targeting agents may be required to selectively target inflammatory breast cancer (IBC) stem cells through Notch inhibition, and that evaluation of microenvironmental influences may shed further light on the potential effects of this inhibitor.



